Category Archives: Pharmaceutical

Recruiting a CFO with Pharma-Specific IP and Patent Knowledge

Healthcare Executive Team 1

At JRG Partners, this is the kind of search we run every day, so this piece reflects practice rather than theory. A pharmaceutical CFO operates in a business where intellectual property is often the principal asset, patent expiry defines the revenue horizon, and litigation […]

How to Recruit a Chief Medical Officer for a Pharma Company

Pharma Executive

Drawing on our executive search practice, we put this together to give employers a grounded, practical view they can act on. The Chief Medical Officer in a pharmaceutical company holds an unusual combination of responsibilities: scientific and clinical leadership, regulatory […]

Building an Executive Team for a Pre-Commercial Biotech

Healthcare Executive Team

This reflects what we have learned at JRG Partners doing exactly this kind of work, the distinctions that matter and the mistakes that recur. Building the executive team for a pre-commercial biotech is an exercise in sequencing under uncertainty, because you are hiring against […]

Hiring Trends in Pharmaceutical Manufacturing Leadership

Pharmaceutical Manufacturing Executive

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Pharmaceutical manufacturing leadership is being reshaped by several forces at once: the growth of biologics and cell and gene therapy, continued […]

What Makes a Great VP of Market Access in Pharma?

Healthcare Business Leadership

Having placed leaders into roles like this repeatedly, we wrote this to give a practitioner’s view rather than generic advice. Market access determines whether a drug that works reaches the patients who need it, and the VP leading it operates at the intersection of evidence, […]

Recruiting for Rare Disease and Orphan Drug Companies

Rare Disease Research

Drawing on our executive search practice, we put this together to give employers a grounded, practical view they can act on. Rare disease and orphan drug companies operate under conditions that make executive recruiting genuinely distinctive: tiny patient populations, close […]